Neutralizing TGF-β promotes anti-tumor immunity of dendritic cells against pancreatic cancer by regulating T lymphocytes

Previous fundamental or clinical trials of dendritic cell (DC) vaccine against pancreatic ductal adenocarcinoma (PDAC) revealed the burgeoning neoadjuvant immunotherapy. Microarray studies indicated that multiple ingredients of the transfer growth factor beta (TGF-β) pathway were overexpressed in PD...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cent Eur J Immunol
Asıl Yazarlar: Pu, Ning, Zhao, Guochao, Gao, Shanshan, Cui, Yutong, Xu, Yadong, Lv, Yang, Nuerxiati, Abulimiti, Wu, Wenchuan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Polish Society of Experimental and Clinical Immunology 2018
Konular:
Experimental Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6102619/
https://ncbi.nlm.nih.gov/pubmed/30135623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceji.2018.77381
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller